Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results
08 août 2024 06h00 HE
|
Prestige Consumer Healthcare Inc.
Revenue of $267.1 Million in Q1, Ahead of Expectations, down 4.4% versus Prior YearEPS of $0.98 and Adjusted EPS of $0.90 in Q1 Compared to $1.06 in the Prior YearCash from Operations of $54.8 Million...
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
02 juil. 2024 16h30 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first quarter earnings release on Thursday, August...
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
06 juin 2024 16h30 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., June 06, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference on...
Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results
14 mai 2024 17h00 HE
|
Prestige Consumer Healthcare Inc.
Revenue of $277.0 Million in Q4 and $1,125.4 Million in Fiscal 2024Solid Consumption Trends in Q4 Offset by Near-Term Supply Chain ConstraintsAchieved Leverage Ratio of 2.8x at Year-End, Below...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
25 avr. 2024 08h30 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 fourth quarter and year-end earnings release on...
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
03 avr. 2024 11h57 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- 1949 was a big year for barf, welcoming the invention of the barf bag and Dramamine®. Seventy-five years later, Dramamine, a Prestige Consumer...
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
08 févr. 2024 06h00 HE
|
Prestige Consumer Healthcare Inc.
Revenue of $282.7 Million in Q3, Up 2.6% Versus Prior YearDiluted EPS of $1.06 in Q3, Up 2.2% Versus Prior YearReduced Leverage Ratio to 2.9x at Quarter EndRaising Full-Year Fiscal 2024 Earnings...
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
02 févr. 2024 09h00 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 1% Tolnaftate...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
10 janv. 2024 17h00 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 third quarter earnings release on Thursday,...
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
22 déc. 2023 09h00 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling one lot of Americaine® 20% Benzocaine...